Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection

eLife

Volumn 3, Issue July2014, 2014, Pages 1-18

  Derebe, Mehabaw G ^a   Zlatkov, Clare M ^a   Gattu, Sureka ^a   Ruhn, Kelly A ^a   Vaishnava, Shipra ^a   Diehl, Gretchen E ^b   MacMillan, John B ^c   Williams, Noelle S ^c   Hooper, Lora V ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; RETINOL; RETINOL BINDING PROTEIN; SAA2 PROTEIN, MOUSE; SAA3 PROTEIN, MOUSE; SERUM AMYLOID A;

ANIMAL; C57BL MOUSE; CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HUMAN; IMMUNOLOGY; INTESTINE; KINETICS; LIVER; METABOLISM; MICROBIOLOGY; MOLECULAR DOCKING; MOUSE; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; TISSUE CULTURE TECHNIQUE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INTESTINES; KINETICS; LIVER; MICE; MICE, INBRED C57BL; MOLECULAR DOCKING SIMULATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RETINOL-BINDING PROTEINS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SERUM AMYLOID A PROTEIN; TISSUE CULTURE TECHNIQUES; VITAMIN A;

EID: 84927694863     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.03206     Document Type: Article

References (51)

1. Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, Terwilliger TC, Urzhumtsev A, Zwart PH, Adams PD. 2012. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallographica Section D, Biological Crystallography 68:352-367. doi: 10.1107/S0907444912001308.
2. Allie SR, Zhang W, Tsai C-Y, Noelle RJ, Usherwood EJ. 2013. Critical role for all-trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation. The Journal of Immunology 190:2178-2187. doi: 10.4049/jimmunol.1201945.
3. Barua AB, Furr HC. 1998. Properties of retinoids. Structure, handling, and preparation. Molecular Biotechnology 10:167-182. doi: 10.1007/BF02760863.
4. Blaner WS. 1989. Retinol-binding protein: the serum transport protein for vitamin A. Endocrine Reviews 10:308-316. doi: 10.1210/edrv-10-3-308.
5. Brockhausen I, Dowler T, Paulsen H. 2009. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2. Biochimica et Biophysica Acta 1790:1244-1257. doi: 10.1016/j.bbagen.2009.05.020.
6. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126-1130. doi: 10.1126/science.1127119.
7. Chiba T, Han CY, Vaisar T, Shimokado K, Kargi A, Chen M-H, Wang S, McDonald TO, O'Brien KD, Heinecke JW, Chait A. 2009. Serum amyloid A3 does not contribute to circulating SAA levels. Journal of Lipid Research 50:1353-1362. doi: 10.1194/jlr.M900089-JLR200.
8. Cogan U, Kopelman M, Mokady S, Shinitzky M. 1976. Binding affinities of retinol and related compounds to retinol binding proteins. European Journal of Biochemistry 65:71-78. doi: 10.1111/j.1432-1033.1976.tb10390.x.
9. Cowan SW, Newcomer ME, Jones TA. 1993. Crystallographic studies on a family of cellular lipophilic transport proteins. Refinement of P2 myelin protein and the structure determination and refinement of cellular retinol-binding protein in complex with all-trans-retinol. Journal of Molecular Biology 230:1225-1246. doi: 10.1006/jmbi.1993.1238.
10. de Beer MC, Beach CM, Shedlofsky SI, de Beer FC. 1991. Identification of a novel serum amyloid A protein in BALB/c mice. The Biochemical Journal 280:45-49.
11. de Beer MC, Kindy MS, Lane WS, de Beer FC. 1994. Mouse serum amyloid A protein (SAA5) structure and expression. The Journal of Biological Chemistry 269:4661-4667.
12. de Beer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, de Beer FC. 1995. Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. Journal of Lipid Research 36:526-534.
13. Eckhardt ER, Witta J, Zhong J, Arsenescu R, Arsenescu V, Wang Y, Ghoshal S, de Beer MC, de Beer FC, de Villiers WJ. 2010. Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis. BMC Gastroenterology 10:133. doi: 10.1186/1471-230X-10-133.
14. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallographica Section D, Biological Crystallography 66:486-501. doi: 10.1107/S0907444910007493.
15. Friedman GD, Blaner WS, Goodman DS, Vogelman JH, Brind JL, Hoover R, Fireman BH, Orentreich N. 1986. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. American Journal of Epidemiology 123:781-789.
16. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, De Lera AR, Lotan R, Mangelsdorf DJ, Gronemeyer H. 2006. International union of pharmacology. LX. retinoic acid receptors. Pharmacological Reviews 58:712-725. doi: 10.1124/pr.58.4.4.
17. Grosdidier A, Zoete V, Michielin O. 2011. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Research 39:W270-W277. doi: 10.1093/nar/gkr366.
18. Hall JA, Cannons JL, Grainger JR, Dos Santos LM, Hand TW, Naik S, Wohlfert EA, Chou DB, Oldenhove G, Robinson M, Grigg ME, Kastenmayaer R, Schwartzberg PL, Belkaid Y. 2011. Essential role for retinoic acid in the promotion of CD4+ T cell effector responses via retinoic acid receptor alpha. Immunity 34:435-447. doi: 10.1016/j.immuni.2011.03.003.
19. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-498. doi: 10.1016/j.cell.2009.09.033.
20. Kanther M, Tomkovich S, Xiaolun S, Grosser MR, Koo J, Flynn EJ, Jobin C, Rawls JF. 2013. Commensal microbiota stimulate systemic neutrophil migration through induction of serum amyloid A. Cellular Microbiology 16:1053-1067. doi: 10.1111/cmi.12257.
21. Lawson ND, Berliner N. 1999. Neutrophil maturation and the role of retinoic acid. Experimental Hematology 27:1355-1367. doi: 10.1016/S0301-472X(99)00085-5.
22. Liu L, Gudas LJ. 2005. Disruption of the lecithin:retinol acyltransferase gene makes mice more susceptible to vitamin A deficiency. The Journal of Biological Chemistry 280:40226-40234. doi: 10.1074/jbc.M509643200.
23. Lu J, Yu Y, Zhu I, Cheng Y, Sun PD. 2014. Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proceedings of the National Academy of Sciences of USA 111:5189-5194. doi: 10.1073/pnas.1322357111.
24. McAdam KP, Sipe JD. 1976. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. The Journal of Experimental Medicine 144:1121-1127. doi: 10.1084/jem.144.4.1121.
25. McClean SW, Ruddel ME, Gross EG, DeGiovanna JJ, Peck GL. 1982. Liquid-chromatographic assay for retinol (vitamin A) and retinol analogs in therapeutic trials. Clinical Chemistry 28:693-696.
26. Meek RL, Benditt EP. 1986. Amyloid A gene family expression in different mouse tissues. The Journal of Experimental Medicine 164:2006-2017. doi: 10.1084/jem.164.6.2006.
27. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-260. doi: 10.1126/science.1145697.
28. Newcomer ME, Jones TA, Aqvist J, Sundelin J, Eriksson U, Rask L, Peterson PA. 1984. The three-dimensional structure of retinol-binding protein. The EMBO Journal 3:1451-1454.
29. Noy N. 2000. Retinoid-binding proteins: mediators of retinoid action. The Biochemical Journal 348:481-495. doi: 10.1042/0264-6021:3480481.
30. Osanai M, Nishikiori N, Murata M, Chiba H, Kojima T, Sawada N. 2007. Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis. Molecular Pharmacology 71:250-258. doi: 10.1124/mol.106.029579.
31. Otwinowski Z, Minor W. 2013. Processing of X-ray diffraction data collected in oscillation mode. Methods in Enzymology 276:307-326. doi: 10.1016/S0076-6879(97)76066-X.
32. Reigstad CS, Bäckhed F. 2010. Microbial regulation of SAA3 expression in mouse colon and adipose tissue. Gut Microbes 1:55-57. doi: 10.4161/gmic.1.1.10514.
33. Reigstad CS, Lundén GÖ, Felin J, Bäckhed F. 2009. Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLOS ONE 4:e5842. doi: 10.1371/journal.pone.0005842.
34. Rosales FJ, Ritter SJ, Zolfaghari R, Smith JE, Ross AC. 1996. Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. Journal of Lipid Research 37:962-971.
35. Sommer A. 2008. Vitamin A deficiency and clinical disease: an historical overview. Journal of Nutrition 138:1835-1839.
36. Spencer SP, Wilhelm C, Yang Q, Hall JA, Bouladoux N, Boyd A, Nutman TB, Urban JF, Wang J, Ramalingam TR, Bhandoola A, Wynn TA, Belkaid Y. 2014. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 343:432-437. doi: 10.1126/science.1247606.
37. Stephensen CB. 2001. Vitamin A, infection, and immune function. Annual Review of Nutrition 21:167-192. doi: 10.1146/annurev.nutr.21.1.167.
38. Stevens FJ. 2004. Hypothetical structure of human serum amyloid A protein. Amyloid 11:71-80. doi: 10.1080/13506120412331272296.
39. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, Gendler SJ, Hansson GC. 2002. Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucα1,2 glycosyltransferase. The Biochemical Journal 367:609-616. doi: 10.1042/BJ20020371.
40. Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS. 1994. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 19:228-235. doi: 10.1006/geno.1994.1052.
41. Uhlar CM, Whitehead AS. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry 265:501-523. doi: 10.1046/j.1432-1327.1999.00657.x.
42. Underwood BA. 2004. Vitamin A deficiency disorders: international efforts to control a preventable "pox". Journal of Nutrition 134:231S-236S.
43. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. 2005. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. The Journal of Biological Chemistry 280:35890-35895. doi: 10.1074/jbc.M505685200.
44. Vogel S, Gamble MV, Blaner WS. 1999. Biosynthesis, absorption, metabolism and transport of retinoids. In: Handbook of Experimental Pharmacology 139:31-95. doi: 10.1007/978-3-642-58483-1_2.
45. Wang L, Lashuel HA, Walz T, Colón W. 2002. Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proceedings of the National Academy of Sciences of USA 99:15947-15952. doi: 10.1073/pnas.252508399.
46. Wang Y, Srinivasan S, Ye Z, Aguilera JJ, Lopez MM, Colón W. 2011. Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. Biochemical and Biophysical Research Communications 407:725-729. doi: 10.1016/j.bbrc.2011.03.090.
47. Whitehead AS, De Beer MC, Steel DM, Rits M, Lelias JM, Lane WS, De Beer FC. 1992. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. The Journal of Biological Chemistry 267:3862-3867.
48. Willett WC, Polk BF, Underwood BA, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG. 1985. Relation of serum vitamins A and E and carotenoids to the risk of cancer. The New England Journal of Medicine 310:430-434. doi: 10.1056/NEJM198402163100705.
49. Yu J, Zhu H, Guo JT, De Beer FC, Kindy MS. 2000. Expression of mouse apolipoprotein SAA1.1 in CE/J mice: isoform-specific effects on amyloidogenesis. Laboratory Investigation 80:1797-1806. doi: 10.1038/labinvest.3780191.
50. Zhang N, Ahsan MH, Purchio AF, West DB. 2005. Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. The Journal of Immunology 174:8125-8134. doi: 10.4049/jimmunol.174.12.8125.
51. Zoete V, Grosdidier A, Cuendet M, Michielin O. 2010. Use of the FACTS solvation model for protein-ligand docking calculations. Application to EADock. Journal of Molecular Recognition 23:457-461. doi: 10.1002/jmr.1012.